Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Ordinary Shares, par value $0.0001 per share
-
Shares outstanding
-
133,765,508
-
Number of holders
-
24
-
Total 13F shares, excl. options
-
11,720,823
-
Shares change
-
+769,498
-
Total reported value, excl. options
-
$34,694,000
-
Value change
-
+$188,969
-
Put/Call ratio
-
48.57%
-
Number of buys
-
13
-
Number of sells
-
-12
-
Price
-
$2.96
Significant Holders of Global Cord Blood Corp - Ordinary Shares, par value $0.0001 per share (CORBF) as of Q2 2022
35 filings reported holding CORBF - Global Cord Blood Corp - Ordinary Shares, par value $0.0001 per share as of Q2 2022.
Global Cord Blood Corp - Ordinary Shares, par value $0.0001 per share (CORBF) has 24 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11,720,823 shares
of 133,765,508 outstanding shares and own 8.76% of the company stock.
Largest 10 shareholders include Oasis Management Co Ltd. (4,761,102 shares), RENAISSANCE TECHNOLOGIES LLC (2,545,983 shares), Man Group plc (1,801,336 shares), BlueCrest Capital Management Ltd (1,452,603 shares), Quinn Opportunity Partners LLC (324,494 shares), NATIXIS ADVISORS, L.P. (199,880 shares), BANK OF AMERICA CORP /DE/ (175,959 shares), FourWorld Capital Management LLC (113,911 shares), MORGAN STANLEY (99,760 shares), and BOOTHBAY FUND MANAGEMENT, LLC (45,564 shares).
This table shows the top 24 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.